Acquisition

Anagenics to buy Bio-First skincare brand for $34,400 in shares

What's the deal? Australia's Anagenics has signed a binding agreement to acquire natural skincare brand Bio-First from Bio deNovo Group for US$32.4K (roughly $34,400). The acquirer, formerly known as Cellmid, will pay entirely in shares — issuing 8,333,333 AN1 shares at US$0 each — with completion expected in November 2026.

What's included? The deal covers Bio-First's intellectual property, product formulations, customer database, and digital assets, plus a pipeline of more than 10 product concepts. The brand brings over 17,000 past purchasers, an email list exceeding 25,000 contacts, and more than 1,700 reviews.

What's the endgame? Anagenics plans to relaunch Bio-First through its BLC Cosmetics arm, using its existing ecommerce platform and professional-beauty channels across clinics, salons, and spas. The all-share structure preserves cash for that relaunch.

Why now? Anagenics says it is reviewing and refocusing its brand portfolio, with further strategic plans aimed at boosting scale and profitability due in the coming year.

Chair Sandy Beard called Bio-First "a highly complementary brand with proven formulations and a substantial existing customer base," adding that the company sees "an attractive opportunity to relaunch the brand through BLC's existing channels."

What could go wrong? This is a small, asset-led deal, and the announcement alone does not establish current demand or commercial traction. Success hinges on whether Anagenics can turn dormant brand assets into actual sales.

The signal: The move fits a broader pattern of beauty businesses buying established brands and scaling them through existing platforms — seen in larger deals such as Pai PartnersDealroom has a profile for this one. Try Dealroom →' agreed purchase of ElemisDealroom has a profile for this one. Try Dealroom → and Avenir Collective's acquisition of Wrinkles SchminklesDealroom has a profile for this one. Try Dealroom →. At this scale, it is a low-cost bet on reactivating an existing customer base rather than a transformative acquisition.

Read more: kalkinemedia.com

Image credit: Generated with Gemini

More top stories